Clinical trial
Placebo Controlled Trial of Bosentan in Scleroderma Patients
NCT00377455 · Georgetown University, Other · Terminated
Key facts
| NCT number | NCT00377455 |
|---|---|
| Title | Placebo Controlled Trial of Bosentan in Scleroderma Patients |
| Official title | Placebo Controlled Trial of Bosentan vs Placebo in NYHA Class I/II Scleroderma Patients With Exercise Induced Pulmonary Hypertension |
| Lead sponsor | Georgetown University, Other |
| Collaborators | Actelion Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Systemic Scleroderma, Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Bosentan, Placebo |
| Enrollment | 5 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Sep 18, 2006 |
| Last update posted | May 24, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: